This HTML5 document contains 64 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n65http://dbkwik.webdatacommons.org/resource/fAnZOPgX14BBmeyZzFuWMA==
n37http://dbkwik.webdatacommons.org/resource/FEsw2hjMwkS_-Qp7I9GdPQ==
n35http://dbkwik.webdatacommons.org/resource/Ve-MprE9xr7KmzC7fEfluA==
n7http://dbkwik.webdatacommons.org/resource/FoTrkbg78aMNEOjFsRom1g==
n64http://dbkwik.webdatacommons.org/resource/pTEKXoXwy_QJD-cbbKl3EQ==
n8http://dbkwik.webdatacommons.org/resource/UZJ15dcXJF4ZbeYXiRKbKQ==
dbrhttp://dbpedia.org/resource/
n42http://dbkwik.webdatacommons.org/resource/VBbxgj4zylzXvbs_j_vNjQ==
n34http://dbkwik.webdatacommons.org/resource/0OlaYhVj3i8Dr2QuFbdmrQ==
n9http://dbkwik.webdatacommons.org/resource/kzLeiV1OHJoX4vjOCfqG3g==
n38http://dbkwik.webdatacommons.org/resource/I1y1aREBq-5GdgQXJavcyg==
n47http://dbkwik.webdatacommons.org/resource/70tKQxX1k3tUt-2-L6_aSA==
n48http://dbkwik.webdatacommons.org/resource/Ru2tRZ62yPExodcXfmYxew==
n23http://dbkwik.webdatacommons.org/resource/AwMXvKnV3mmqn1s7HyWIEg==
n29http://dbkwik.webdatacommons.org/resource/n-1HJPtF__dJXiHg6JXsFA==
n6http://dbkwik.webdatacommons.org/resource/UaPiBmh6CNU4wLDXTdcApg==
n14http://dbkwik.webdatacommons.org/resource/XNetZKVMzihHMOQJF-e3wQ==
n12http://dbkwik.webdatacommons.org/resource/Jl3-1_HlRe9XBq22Yl0TCQ==
dctermshttp://purl.org/dc/terms/
n2http://dbkwik.webdatacommons.org/resource/yGh2T6zFBzGueFB10RokZg==
n13http://dbkwik.webdatacommons.org/en.mind-control/property/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n22http://dbkwik.webdatacommons.org/resource/EsMLuNPdDGyo-recm4X0eA==
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n27http://dbkwik.webdatacommons.org/resource/D1kh2tiMXfP6QfherhjC1A==
n44http://dbkwik.webdatacommons.org/resource/gYVDezYGGoGABtUsQfc9kg==
n30http://dbkwik.webdatacommons.org/resource/pQKP3WKOJ1mtIio3fJfI5Q==
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://dbkwik.webdatacommons.org/resource/UYKBIMAgFv-tX_aAELnUMA==
n52http://dbkwik.webdatacommons.org/resource/9KEChOD4WuS-qMXEhbD5kg==
n39http://dbkwik.webdatacommons.org/resource/4lcxDJXEDDXpaztmygoaUg==
n62http://dbkwik.webdatacommons.org/resource/u4sl16klL5ihX4qmRN0fAg==
n59http://dbkwik.webdatacommons.org/resource/CXIq3NRyYahsTmLHAqkpkw==
n4http://dbkwik.webdatacommons.org/resource/sv1tNrby5-T2p_fptsG_8Q==
n24http://dbkwik.webdatacommons.org/resource/e6UNCHolHprFdgy5CwD2Bg==
n56http://dbkwik.webdatacommons.org/resource/ZC7fM7jBbLa01Vg2LVDhDw==
n54http://dbkwik.webdatacommons.org/resource/MWJfRo4diufieFDX88Ae5g==
n60http://dbkwik.webdatacommons.org/resource/suUxqlKJXGMkgs6kJq_i5w==
n5http://dbkwik.webdatacommons.org/mind-control/property/
n45http://dbkwik.webdatacommons.org/resource/KketW6aJHsrcrB3k6DNs6g==
n16http://dbkwik.webdatacommons.org/resource/XMysP69-PG5mCn_DfbN40w==
n61http://dbkwik.webdatacommons.org/resource/ZRTN0Trxs9mTE8dJV1krNQ==
n40http://dbkwik.webdatacommons.org/resource/BDJ4Z2HIHgkuNXPVweGFhA==
n31http://dbkwik.webdatacommons.org/resource/8xuCjbkFRwKfZHJv1skHRw==
n15http://dbkwik.webdatacommons.org/resource/y3wWFmMGv7Vtk_XT0bYvaw==
n55http://dbkwik.webdatacommons.org/resource/cRzHtefrfagiHjZk4xWojg==
n25http://dbkwik.webdatacommons.org/resource/AaGpNMKXeCEx6k1ovZIRVg==
n51http://dbkwik.webdatacommons.org/resource/J7GHflQWM4FNz4RbMMfiuQ==
n43http://dbkwik.webdatacommons.org/resource/xmZ8NJkc0PAvUcoRG7-KIQ==
n26http://dbkwik.webdatacommons.org/resource/MEfQrXP4axjeEtODhN62LA==
n11http://dbkwik.webdatacommons.org/military/property/
n19http://dbkwik.webdatacommons.org/resource/_PIXzsbyHSbzkvdebimXhQ==
n57http://dbkwik.webdatacommons.org/resource/b14y2U4Uf4ytSJSYaWZvug==
n32http://dbkwik.webdatacommons.org/resource/cAtDMkOGzyAfQYqz49ioOQ==
n28http://dbkwik.webdatacommons.org/ontology/
n58http://dbkwik.webdatacommons.org/resource/OAWTD2PCxEM6Cv6CtEyqjQ==
n63http://dbkwik.webdatacommons.org/resource/-a7xNrBa2O1Fx66X6GNw6g==
n36http://dbkwik.webdatacommons.org/resource/lzSrMazqNRE2z3bHseehmA==
n33http://dbkwik.webdatacommons.org/resource/menn55B3vd6O5iqJkTSAmQ==
n10http://dbkwik.webdatacommons.org/resource/7QqrmLN4ngc-iKB3jaW5_g==
n21http://dbkwik.webdatacommons.org/resource/w5wz9akF08ZBl9rm9QSA2A==
n53http://dbkwik.webdatacommons.org/resource/mv8MhcV-51BWZN8xW1K0zw==
n20http://dbkwik.webdatacommons.org/resource/9vTAdVKHeewrBOSTg93zFw==
n46http://dbkwik.webdatacommons.org/resource/ZWhrFSeaBSdXsoxr4ERgEA==
n41http://dbkwik.webdatacommons.org/resource/DTnB8GEy50I_t4w3GrLaRQ==
owlhttp://www.w3.org/2002/07/owl#
Subject Item
n2:
rdfs:label
3-Quinuclidinyl benzilate 3-Quinuclidinyl benzilate
rdfs:comment
3-quinuclidinyl benzilate (QNB, BZ, EA-2277), full chemical name 1-azabicyclo[2.2.2]Oct-3-yl α-hydroxy-α-phenylbenzeneacetate, is an odorless military incapacitating agent. Its NATO code is BZ. The Iraqi incapacitating agent Agent 15 is believed either to be the same as or similar to BZ. BZ is a glycolate anticholinergic compound related to atropine, scopolamine, hyoscyamine, and other deliriants. Dispersal would be as an aerosolized solid (primarily for inhalation) or as agent dissolved in one or more solvents for ingestion or percutaneous absorption. 3-quinuclidinyl benzilate (QNB, BZ, EA-2277), full chemical name 1-azabicyclo[2.2.2]Oct-3-yl α-hydroxy-α-phenylbenzeneacetate, is an odorless military incapacitating agent. Its NATO code is BZ. The Iraqi incapacitating agent Agent 15 is believed either to be the same as or similar to BZ. BZ is a glycolate anticholinergic compound related to atropine, scopolamine, hyoscyamine, and other deliriants. Dispersal would be as an aerosolized solid (primarily for inhalation) or as agent dissolved in one or more solvents for ingestion or percutaneous absorption. 3-Quinuclidinyl benzilate (QNB, BZ, EA-2277), IUPAC name 1-azabicyclo[2.2.2]oct-3-yl 2-hydroxy-2,2-diphenylacetate, is an odorless military incapacitating agent. Its NATO code is BZ. BZ is a glycolate anticholinergic compound related to atropine, scopolamine, hyoscyamine, and other deliriants. Dispersal would be as an aerosolized solid (primarily for inhalation) or as agent dissolved in one or more solvents for ingestion or percutaneous absorption. Production of BZ is controlled under schedule 2 of the Chemical Weapons Convention.
owl:sameAs
dbr:3-Quinuclidinyl_benzilate
n56:
3
n61:
3
dcterms:subject
n4: n7: n16: n19: n20: n30: n33: n35: n40: n44: n45: n48: n53: n55: n57: n58: n59: n65:
n13:wikiPageUsesTemplate
n14: n18: n37: n39: n60: n62: n63:
n11:wikiPageUsesTemplate
n12: n15: n21: n25: n26: n27: n31: n32: n38: n43: n47: n52: n64:
n5:wikiPageUsesTemplate
n6: n8: n22: n23: n36: n46: n51:
n34:
125
n41:
Space filling model
n24:
477220191
n9:
3
n10:
Bonding model
n54:
125
n29:
changed
n42:
1
n28:abstract
3-Quinuclidinyl benzilate (QNB, BZ, EA-2277), IUPAC name 1-azabicyclo[2.2.2]oct-3-yl 2-hydroxy-2,2-diphenylacetate, is an odorless military incapacitating agent. Its NATO code is BZ. BZ is a glycolate anticholinergic compound related to atropine, scopolamine, hyoscyamine, and other deliriants. Dispersal would be as an aerosolized solid (primarily for inhalation) or as agent dissolved in one or more solvents for ingestion or percutaneous absorption. Acting as a competitive inhibitor of acetylcholine at postsynaptic and postjunctional muscarinic receptor sites in smooth muscle, exocrine glands, autonomic ganglia, and the brain, BZ decreases the effective concentration of acetylcholine seen by receptors at these sites. Thus, BZ causes PNS effects that in general are the opposite of those seen in nerve agent poisoning. CNS effects include stupor, confusion, and confabulation with concrete and panoramic illusions and hallucinations, and with regression to primitive, involuntary behaviors such as floccillation and disrobing. Physostigmine, which increases the concentration of acetylcholine in synapses and in neuromuscular and neuroglandular junctions, is a specific antidote. Production of BZ is controlled under schedule 2 of the Chemical Weapons Convention. 3-quinuclidinyl benzilate (QNB, BZ, EA-2277), full chemical name 1-azabicyclo[2.2.2]Oct-3-yl α-hydroxy-α-phenylbenzeneacetate, is an odorless military incapacitating agent. Its NATO code is BZ. The Iraqi incapacitating agent Agent 15 is believed either to be the same as or similar to BZ. BZ is a glycolate anticholinergic compound related to atropine, scopolamine, hyoscyamine, and other deliriants. Dispersal would be as an aerosolized solid (primarily for inhalation) or as agent dissolved in one or more solvents for ingestion or percutaneous absorption. Acting as a competitive inhibitor of acetylcholine at postsynaptic and postjunctional muscarinic receptor sites in smooth muscle, exocrine glands, autonomic ganglia, and the brain, BZ decreases the effective concentration of acetylcholine seen by receptors at these sites. Thus, BZ causes peripheral nervous system (PNS) effects that in general are the opposite of those seen in nerve agent poisoning. Central nervous system (CNS) effects include stupor, confusion, and confabulation with concrete and panoramic illusions and hallucinations, and with regression to automatic "phantom" behaviors such as plucking and disrobing. Physostigmine, which increases the concentration of acetylcholine in synapses and in neuromuscular and neuroglandular junctions, is a specific antidote. Production of BZ is controlled under schedule 2 of the Chemical Weapons Convention. 3-quinuclidinyl benzilate (QNB, BZ, EA-2277), full chemical name 1-azabicyclo[2.2.2]Oct-3-yl α-hydroxy-α-phenylbenzeneacetate, is an odorless military incapacitating agent. Its NATO code is BZ. The Iraqi incapacitating agent Agent 15 is believed either to be the same as or similar to BZ. BZ is a glycolate anticholinergic compound related to atropine, scopolamine, hyoscyamine, and other deliriants. Dispersal would be as an aerosolized solid (primarily for inhalation) or as agent dissolved in one or more solvents for ingestion or percutaneous absorption. Acting as a competitive inhibitor of acetylcholine at postsynaptic and postjunctional muscarinic receptor sites in smooth muscle, exocrine glands, autonomic ganglia, and the brain, BZ decreases the effective concentration of acetylcholine seen by receptors at these sites. Thus, BZ causes peripheral nervous system (PNS) effects that in general are the opposite of those seen in nerve agent poisoning. Central nervous system (CNS) effects include stupor, confusion, and confabulation with concrete and panoramic illusions and hallucinations, and with regression to automatic "phantom" behaviors such as plucking and disrobing. Physostigmine, which increases the concentration of acetylcholine in synapses and in neuromuscular and neuroglandular junctions, is a specific antidote. Production of BZ is controlled under schedule 2 of the Chemical Weapons Convention.